semaglutide compounded Personalized Semaglutide | C187H291N45O59 | CID
Description
The mutation sequence targeting YAP T83A : T83AF: AACGTGCCCCAGgCCGTGCCCATGAGGCTCCG T83AR: ACGGcCTGGGGCACGTTGGCCGTCTTGGGGTT The mutation sequence targeting YAP S109A : S109AF: ACAGGCCgctACTGATGCAGGCACTGCAGGAG S109AR: CATCAGTagcGGCCTGTCGGGAGTGGGATTTG The mutation sequence targeting YAP T241A : T241AF: AAGCCATGgCTCAGGATGGAGAAATTTACTATATAAACC T241AR: ATCCTGAGcCATGGCTTGTTCCCATCCATCAG The sgRNA sequence targeting human EIF3H: sghEIF3H1F: caccGCGTCCCGCAAGGAAGGTAC sghEIF3H1R: aaacGTACCTTCCTTGCGGGACGC sghEIF3H2F: caccGTATGGCTCATTCGTTACCC sghEIF3H2R: aaacGGGTAACGAATGAGCCATAC sghEIF3H3F: caccGATCAATGTTTACATGGCGA sghEIF3H3R: aaacTCGCCATGTAAACATTGATC The sgRNA sequence targeting mouse EIF3H: sgmEIF3H1F: caccGGCAGTTGGTAATCTCTAGC sgmEIF3H1R: aaacGCTAGAGATTACCAACTGCC sgmEIF3H2F: caccGGCTCTACCGCCACCTCCTC sgmEIF3H2R: aaacGAGGAGGTGGCGGTAGAGCC sgmEIF3H3F: caccGTTCCCGTTCCCCCAGCACA sgmEIF3H3R: aaacTGTGCTGGGGGAACGGGAAC Cell Transfection and Stable Cell Line Construction with Lentivirus Transduction Cells are transfected with PEI STAR (TOCRIS) Transfection Reagent following the user manual
it must be refrigerated and used within the timeframe recommended on the packaging

J Nephropharmacol 5(1):4956 Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M et al (2011) Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

The goal of the first four weeks is GI tolerance assessment, not maximum dosing

If you find yourself feeling jittery, an electrolyte supplement may help balance your system

However, the results in humans are not entirely consistent with those in animals
